MDMA-assisted Psychotherapy in Twelve People With War and Terrorism-related Posttraumatic Stress Disorder (PTSD)
Phase of Trial: Phase II
Latest Information Update: 19 Apr 2011
Price : $35 *
At a glance
- Drugs Methylenedioxymetamfetamine (Primary)
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- Acronyms MP-3
- 01 Apr 2011 Status changed from active, no longer recruiting to discontinued, according to ClinicalTrials.gov.
- 19 Jul 2010 Integrated additional information from the Multidisciplinary Association for Psychedelic Studies website.
- 22 Sep 2009 Planned end date changed from 1 Apr 2009 to 1 Dec 2010 as reported by ClinicalTrials.gov.